Teva Pharmaceuticals recalls Adenosine Injection vials due to potential lack of sterility. This could cause infections if used improperly. Affected lots expire April 2023.
Lack of Assurance of Sterility
Teva Pharmaceuticals is recalling Adenosine Injection vials that may not be sterile, which could lead to infections if used. This is a serious safety issue for patients needing this medication.
The vials may not be sterile, meaning bacteria could contaminate the medication. If injected, this could cause serious infections or health complications.
Patients prescribed Adenosine Injection by a doctor. Those using the recalled vials (lot 100022400, expiring April 2023) are at risk of infection.
Check for the lot number 100022400 on the vial label. The vial expires April 2023. This product is only available by prescription.
Immediately discard the recalled vial if you have it.
No, the recalled vials may not be sterile and could cause infections if used.
Discard the vial immediately and contact your doctor for alternatives.
The recalled vials were manufactured with lot number 100022400 and expire April 2023.
We’ve drafted a message you can send Teva Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0740-2021 — Teva Pharmaceuticals Teva Pharmaceuticals Hello, I own a Teva Pharmaceuticals that is covered by recall D-0740-2021 from Teva Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
